148 related articles for article (PubMed ID: 34568359)
1. Influence of
Chan SW; Chu TTW; Ho CS; Kong APS; Tomlinson B; Zeng W
Front Med (Lausanne); 2021; 8():683498. PubMed ID: 34568359
[No Abstract] [Full Text] [Related]
2. Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients.
Okda SM; El-Bassiouny NA; El Amrawy AM; Salahuddin A; Elonsy SM; Kassem AB
Br J Clin Pharmacol; 2024 Jun; ():. PubMed ID: 38886107
[TBL] [Abstract][Full Text] [Related]
3. Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension.
Zeng W; Chu TTW; Ho CS; Lo CWS; Chan ASL; Kong APS; Tomlinson B; Chan SW
Front Cardiovasc Med; 2022; 9():842875. PubMed ID: 35433877
[TBL] [Abstract][Full Text] [Related]
4. Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
Kim KA; Park IB; Park JY
Eur J Clin Pharmacol; 2018 Oct; 74(10):1281-1289. PubMed ID: 29947950
[TBL] [Abstract][Full Text] [Related]
5. Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol.
Nozawa T; Taguchi M; Tahara K; Hashimoto Y; Igarashi N; Nonomura M; Kato B; Igawa A; Inoue H
J Cardiovasc Pharmacol; 2005 Nov; 46(5):713-20. PubMed ID: 16220080
[TBL] [Abstract][Full Text] [Related]
6. Effects of
Charoenchokthavee W; Areepium N; Panomvana D; Sriuranpong V
Breast Cancer (Dove Med Press); 2017; 9():249-256. PubMed ID: 28450788
[TBL] [Abstract][Full Text] [Related]
7. Effect of bisoprolol on central aortic systolic pressure in Chinese hypertensive patients after the initial dose and long-term treatment.
Zeng W; Tomlinson B
Bosn J Basic Med Sci; 2022 Jun; 22(3):427-434. PubMed ID: 34716698
[TBL] [Abstract][Full Text] [Related]
8. Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study.
Mohammed Alkreathy H; Mohammed Eid Alsayyid K; Alaama JY; Al Ghalayini K; Karim S; Esmat A; Damanhouri ZA
Saudi J Biol Sci; 2020 Oct; 27(10):2727-2732. PubMed ID: 32994732
[TBL] [Abstract][Full Text] [Related]
9. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
Belmonte C; Ochoa D; Román M; Saiz-Rodríguez M; Wojnicz A; Gómez-Sánchez CI; Martín-Vílchez S; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):596-605. PubMed ID: 29325225
[TBL] [Abstract][Full Text] [Related]
10. The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension.
Lefebvre J; Poirier L; Poirier P; Turgeon J; Lacourciere Y
Br J Clin Pharmacol; 2007 May; 63(5):575-82. PubMed ID: 17094780
[TBL] [Abstract][Full Text] [Related]
11. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
Swaisland HC; Cantarini MV; Fuhr R; Holt A
Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
Lewin AJ; Lueg MC; Targum S; Cardenas P
Clin Cardiol; 1993 Oct; 16(10):732-6. PubMed ID: 8222387
[TBL] [Abstract][Full Text] [Related]
13. Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
Ju S; Gao Y; Cao X; Zhang XF; Yan CC; Liu FT
Genet Test Mol Biomarkers; 2017 Sep; 21(9):539-546. PubMed ID: 28872889
[TBL] [Abstract][Full Text] [Related]
14. Effects of genetic factors on the pharmacokinetics and pharmacodynamics of amlodipine in primary hypertensive patients.
Guo C; Pei QI; Tan H; Huang Z; Yuan H; Yang G
Biomed Rep; 2015 Mar; 3(2):195-200. PubMed ID: 26075072
[TBL] [Abstract][Full Text] [Related]
15. Effects of CYP2D6*10, CYP3A5*3, CYP1A2*1F, and ABCB1 C3435T polymorphisms on the pharmacokinetics of flecainide in healthy Chinese subjects.
Hu M; Yang YL; Fok BS; Chan SW; Chu TT; Poon EW; Yin OQ; Lee VH; Tomlinson B
Drug Metabol Drug Interact; 2012 Jan; 27(1):33-9. PubMed ID: 22718623
[TBL] [Abstract][Full Text] [Related]
16. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
[TBL] [Abstract][Full Text] [Related]
17. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety.
Saiz-Rodríguez M; Belmonte C; Derqui-Fernández N; Cabaleiro T; Román M; Ochoa D; Talegón M; Ovejero-Benito MC; Abad-Santos F
Pharmacogenomics; 2017 Nov; 18(16):1491-1502. PubMed ID: 29061081
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol.
Fontana V; Turner RM; Francis B; Yin P; Pütz B; Hiltunen TP; Ruotsalainen S; Kontula KK; Müller-Myhsok B; Pirmohamed M
Pharmgenomics Pers Med; 2022; 15():249-260. PubMed ID: 35356681
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
